Jörg Reinhardt news from FierceVaccines
News
Novartis to offer data on pre-pandemic jabs
Novartis hasn't given up in its pursuit of profits. The Swiss company has been making an argument for use of its experimental flu vaccine ahead of any potential outbreak. Vaccines chief Jörg Read more...
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight